Breast cancer treatment: new hope for patients with aggressive breast cancer

A team of researcher has identified a method for treating particularly aggressive forms of breast cancer that could potentially save thousands of lives each year.

By: ANI | | Updated: March 20, 2018 10:03 am

You must know about symptoms of breast cancer © Shutterstock

A team of researchers has identified a method for treating particularly aggressive forms of breast cancer that could potentially save thousands of lives each year. According to results from a SWOG clinical trial, those with tough-to-treat triple negative breast cancer, whose tumors also don’t allow for double-strand DNA repair, fare better when treated with a common adjuvant breast cancer chemotherapy combination. Also Read - New AI breast cancer diagnostic tool developed

Also Read - Researchers discover new method to reduce chemotherapy doses for patients

The trial results showed that a well-established drug combination – adjuvant doxorubicin and cyclophosphamide (AC) chemotherapy – works well in this patient population. Also Read - Here is how to manage hair loss and other side-effects of cancer treatment

The results also showed the value of collecting and preserving cancer tumor tissue. University of Kansas Cancer Center’s Priyanka Sharma and her team used nearly 20-year-old tumour samples stored in SWOG’s biospecimen bank to conduct their analysis.

“We learned three interesting things from this trial,” Sharma said. “First, we showed that assays tested in our study worked well in very old tissue samples. We also learned that 25 percent of triple negative breast cancer patients harbored BRCA 1 or BRCA2 mutations and tumors in these patients were HRD positive.”

“However, presence of HRD was not restricted to just patients with BRCA mutations, as among patients without BRCA mutations, 55 percent also demonstrated tumor HRD. Finally, and most importantly, we learned that 67 percent of triple negative breast cancer patients – a solid majority – respond well to a standard, backbone chemotherapy combination. So, while, AC chemo is an old treatment, for many, it’s still a good one. HRD status is a biomarker that, when identified, can potentially help a physician best tailor a chemotherapy treatment for that particular triple negative breast cancer patient.”

The study is published in Annals of Oncology. (ANI)

Published : March 20, 2018 10:02 am | Updated:March 20, 2018 10:03 am

Read Disclaimer

World Oral Health Day 2018: 7 harmful habits that are destroying your tooth enamel

Custom-made foot orthoses no different than over-the-counter insoles

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com

+91 – 22 – 6697 1234

91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

We respect your privacy

World Oral Health Day 2018: 7 harmful habits that are destroying your tooth enamel

Custom-made foot orthoses no different than over-the-counter insoles

New AI breast cancer diagnostic tool developed

Researchers discover new method to reduce chemotherapy doses for patients

Here is how to manage hair loss and other side-effects of cancer treatment

Tiny bubbles in our body to fight cancer better than chemo

New study to help prevent hair loss from chemotherapy

About The health Site

Useful Links